These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 34331185

  • 1. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
    Tranos P, Tsiropoulos GN, Koronis S, Vakalis A, Asteriadis S, Stavrakas P.
    Int Ophthalmol; 2021 Dec; 41(12):4037-4046. PubMed ID: 34331185
    [Abstract] [Full Text] [Related]

  • 2. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
    Szeto SKH, Tsang CW, Mohamed S, Lee GKY, Lok JKH, Hui VWK, Tsang KK, Chen LJ, Brelen M, Lai TYY.
    Ophthalmologica; 2024 Dec; 247(2):118-132. PubMed ID: 38408445
    [Abstract] [Full Text] [Related]

  • 3. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration.
    Barayev E, Tiosano A, Zlatkin R, Elul R, Dotan A, Hadayer A, Gal-Or O, Ehrlich R.
    Eur J Ophthalmol; 2024 May; 34(3):825-833. PubMed ID: 37715632
    [Abstract] [Full Text] [Related]

  • 4. Sequential tissue plasminogen activator, pneumatic displacement, and anti-VEGF treatment for submacular hemorrhage.
    Bardak H, Bardak Y, Erçalık Y, Erdem B, Arslan G, Timlioglu S.
    Eur J Ophthalmol; 2018 May; 28(3):306-310. PubMed ID: 29148027
    [Abstract] [Full Text] [Related]

  • 5. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y, Shimada H, Mori R, Tanaka K, Yuzawa M.
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [Abstract] [Full Text] [Related]

  • 7. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM, Sherman MP, Barr CC, Schaal S.
    Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
    [Abstract] [Full Text] [Related]

  • 8. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [Abstract] [Full Text] [Related]

  • 9. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
    de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC.
    Retina; 2016 May; 36(5):914-25. PubMed ID: 26807631
    [Abstract] [Full Text] [Related]

  • 10. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
    Gok M, Karabaş VL, Aslan MS, Kara Ö, Karaman S, Yenihayat F.
    Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
    [Abstract] [Full Text] [Related]

  • 11. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.
    Jackson TL, Bunce C, Desai R, Hillenkamp J, Lee CN, Lois N, Peto T, Reeves BC, Steel DH, Edwards RT, van Meurs JC, Wafa H, Wang Y.
    Trials; 2022 Jan 31; 23(1):99. PubMed ID: 35101110
    [Abstract] [Full Text] [Related]

  • 12. Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration.
    Avcı R, Mavi Yıldız A, Çınar E, Yılmaz S, Küçükerdönmez C, Akalp FD, Avcı E.
    Turk J Ophthalmol; 2021 Feb 25; 51(1):38-44. PubMed ID: 33631914
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2012 May 25; 96(5):708-13. PubMed ID: 22174095
    [Abstract] [Full Text] [Related]

  • 14. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
    Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P, Ober M, Mahmoud TH.
    Ophthalmol Retina; 2018 Mar 25; 2(3):180-186. PubMed ID: 31047581
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E, Peroglio Deiro A, Mete M, Sartore M, Polito A, Prigione G, Guerriero M, Pertile G.
    Ophthalmologica; 2020 Mar 25; 243(3):224-235. PubMed ID: 31905361
    [Abstract] [Full Text] [Related]

  • 16. Comparison between different techniques for treatment of submacular haemorrhage due to Age-Related Macular Degeneration.
    Kishikova L, Saad AAA, Vaideanu-Collins D, Isac M, Hamada D, El-Haig WM.
    Eur J Ophthalmol; 2021 Sep 25; 31(5):2621-2624. PubMed ID: 32993349
    [Abstract] [Full Text] [Related]

  • 17. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
    Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan 25; 248(1):5-11. PubMed ID: 19669780
    [Abstract] [Full Text] [Related]

  • 18. Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes.
    Abdulaal M, Donkor R, Robertson J, Lewis S, Miller DG, Schartman J, Platt S, Coney JM.
    Can J Ophthalmol; 2024 Oct 25; 59(5):e582-e589. PubMed ID: 37925165
    [Abstract] [Full Text] [Related]

  • 19. Fundus Autofluorescence Patterns in Subretinal Hemorrhages Associated with Neovascular Age-Related Macular Degeneration.
    Nawrocka ZA, Nawrocki J.
    Ophthalmologica; 2024 Oct 25; 247(1):58-64. PubMed ID: 38113868
    [Abstract] [Full Text] [Related]

  • 20. The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-related Macular Degeneration.
    Shin KH, Lee TG, Kim JH, Kim JW, Kim CG, Lee DW, Han JI, Lew YJ, Cho HJ.
    Korean J Ophthalmol; 2016 Oct 25; 30(5):369-376. PubMed ID: 27729757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.